NO20055443L - Stabilisert farmasoytisk produkt - Google Patents
Stabilisert farmasoytisk produktInfo
- Publication number
- NO20055443L NO20055443L NO20055443A NO20055443A NO20055443L NO 20055443 L NO20055443 L NO 20055443L NO 20055443 A NO20055443 A NO 20055443A NO 20055443 A NO20055443 A NO 20055443A NO 20055443 L NO20055443 L NO 20055443L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical product
- stabilized pharmaceutical
- gasket
- stabilized
- protect
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
- B65D81/26—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
- B65D81/26—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
- B65D81/266—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/06—Packaging for specific medical equipment
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Mechanical Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0312148.0A GB0312148D0 (en) | 2003-05-28 | 2003-05-28 | Stabilized pharmaceutical products |
PCT/GB2004/002249 WO2004105727A2 (en) | 2003-05-28 | 2004-05-27 | Stabilized pharmaceutical product |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20055443L true NO20055443L (no) | 2005-11-17 |
Family
ID=9958829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055443A NO20055443L (no) | 2003-05-28 | 2005-11-17 | Stabilisert farmasoytisk produkt |
Country Status (22)
Country | Link |
---|---|
US (4) | US7736673B2 (es) |
EP (1) | EP1626913B1 (es) |
JP (1) | JP5175048B2 (es) |
KR (1) | KR20060023539A (es) |
CN (1) | CN1832890A (es) |
AR (1) | AR047619A1 (es) |
AT (1) | ATE457163T1 (es) |
AU (1) | AU2004243223A1 (es) |
BR (1) | BRPI0410701A (es) |
CA (1) | CA2527088C (es) |
DE (1) | DE602004025463D1 (es) |
ES (1) | ES2340681T3 (es) |
GB (1) | GB0312148D0 (es) |
MA (1) | MA27804A1 (es) |
MX (1) | MXPA05012757A (es) |
NO (1) | NO20055443L (es) |
PL (1) | PL1626913T3 (es) |
RS (1) | RS20050882A (es) |
RU (1) | RU2337667C2 (es) |
TW (1) | TW200509989A (es) |
WO (1) | WO2004105727A2 (es) |
ZA (1) | ZA200509099B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1572217B1 (en) | 2002-12-12 | 2008-08-20 | Nycomed GmbH | Combination medicament of r,r-formoterol and ciclesonide |
GB0312148D0 (en) * | 2003-05-28 | 2003-07-02 | Aventis Pharma Ltd | Stabilized pharmaceutical products |
AU2004246819A1 (en) | 2003-06-13 | 2004-12-23 | Nycomed Gmbh | Formoterol and ciclesonide combination |
GB0315889D0 (en) | 2003-07-08 | 2003-08-13 | Aventis Pharma Ltd | Stable pharmaceutical products |
EP1803457A1 (en) * | 2005-12-30 | 2007-07-04 | Krka Tovarna Zdravil, D.D., Novo Mesto | Pharmaceutical composition containing montelukast |
EP1976522B2 (en) * | 2005-12-30 | 2019-07-03 | KRKA, tovarna zdravil, d.d., Novo mesto | Pharmaceutical composition containing montelukast |
US20090308772A1 (en) * | 2006-03-17 | 2009-12-17 | Abrams William S | Moisture-tight primary packaging for a dry powder inhaler |
EP2254630A1 (de) * | 2008-02-20 | 2010-12-01 | Boehringer Ingelheim International GmbH | Pulverinhalatoren |
EP4403231A2 (en) | 2009-02-26 | 2024-07-24 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
EP2526417A4 (en) * | 2010-01-22 | 2013-09-11 | Bayer Healthcare Llc | DRYING AGENT WITH INCREASED ACCURACY |
US9233788B2 (en) | 2010-01-22 | 2016-01-12 | Bayer Healthcare Llc | Biosensor desiccant system having enhanced measurement performance |
WO2011093814A2 (en) * | 2010-01-29 | 2011-08-04 | Mahmut Bilgic | A pharmaceutical combination comprising formoterol and ciclesonide |
AU2011298409B2 (en) | 2010-08-31 | 2013-11-21 | Glaxo Group Limited | Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same |
TR201007250A2 (tr) * | 2010-09-01 | 2012-03-21 | Bi̇lgi̇ç Mahmut | Selobioz içeren formülasyon. |
TWI565943B (zh) * | 2011-07-22 | 2017-01-11 | 拜耳保健公司 | 具有增進測量性能之生物感測器乾燥劑系統 |
KR101851425B1 (ko) | 2011-09-02 | 2018-04-23 | 네스텍 소시에테아노님 | 치료 효능 결정을 위한 신호 경로 단백질의 프로파일링 |
WO2013109212A1 (en) * | 2012-01-16 | 2013-07-25 | Mahmut Bilgic | Dry powder formulations comprising ciclesonide |
KR20130140358A (ko) | 2012-06-14 | 2013-12-24 | 한미약품 주식회사 | 살메테롤 지나포산염, 플루티카손 프로피오네이트 및 티오트로피움 브로마이드를 포함하는 흡입 제형용 건조 분말 및 이의 제조방법 |
WO2014122600A1 (en) | 2013-02-05 | 2014-08-14 | Nestec S.A. | Methods of selecting combination therapy for colorectal cancer patients |
CN104644618A (zh) * | 2013-11-19 | 2015-05-27 | 上海医药工业研究院 | 一种干粉吸入剂及其制备方法 |
SG11202003384XA (en) * | 2017-10-16 | 2020-05-28 | Faes Farma Sa | Aqueous compositions comprising bilastine and mometasone |
US10537585B2 (en) | 2017-12-18 | 2020-01-21 | Dexcel Pharma Technologies Ltd. | Compositions comprising dexamethasone |
CN118414147A (zh) * | 2021-12-21 | 2024-07-30 | 凯西制药公司 | 填充在具有改善的耐湿性的吸入器中的干粉制剂 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6536427B2 (en) * | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
AU650953B2 (en) * | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
SE9302777D0 (sv) * | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
US6586006B2 (en) * | 1994-08-04 | 2003-07-01 | Elan Drug Delivery Limited | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
SE9700134D0 (sv) | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
DE19541689A1 (de) | 1994-11-14 | 1996-05-15 | Byk Gulden Lomberg Chem Fab | Kombinationsarzneimittel |
US5612053A (en) * | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US6040344A (en) | 1996-11-11 | 2000-03-21 | Sepracor Inc. | Formoterol process |
ATE234604T1 (de) * | 1998-08-04 | 2003-04-15 | Jago Res Ag | Medizinische aerosolformulierungen |
EP1283036B2 (de) * | 1998-11-13 | 2020-01-01 | Jagotec AG | Multidosis-Trockenpulverinhalator mit Pulverreservoir |
FR2786395A1 (fr) * | 1998-12-01 | 2000-06-02 | Virbac Sa | Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications |
US6352152B1 (en) * | 1998-12-18 | 2002-03-05 | Smithkline Beecham Corporation | Method and package for storing a pressurized container containing a drug |
US6119853A (en) * | 1998-12-18 | 2000-09-19 | Glaxo Wellcome Inc. | Method and package for storing a pressurized container containing a drug |
US6390291B1 (en) * | 1998-12-18 | 2002-05-21 | Smithkline Beecham Corporation | Method and package for storing a pressurized container containing a drug |
SE9903995D0 (sv) * | 1999-11-03 | 1999-11-03 | Astra Ab | New combination |
GB9928311D0 (en) | 1999-11-30 | 2000-01-26 | Novartis Ag | Organic compounds |
GB0012260D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
GB0012261D0 (en) | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel process |
HUP0302005A3 (en) | 2000-05-23 | 2006-07-28 | Glaxo Group Ltd | Aerosol container for formulations of salmeterol xinafoate |
GB0015043D0 (en) * | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Medicament dispenser |
FI20002177A0 (fi) | 2000-10-02 | 2000-10-02 | Orion Yhtymae Oyj | Uusi yhdistelmä astman hoitoon |
US20030055026A1 (en) * | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
US6472563B1 (en) * | 2001-11-09 | 2002-10-29 | Sepracor Inc. | Formoterol tartrate process and polymorph |
NZ532673A (en) * | 2001-11-17 | 2008-07-31 | Aventis Pharma Ltd | Package comprising a medicament, a component that gradually releases a gaseous substance and an adsorbent material |
GB0207899D0 (en) | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and cielesonide aerosol formulations |
JP2004051502A (ja) * | 2002-07-17 | 2004-02-19 | Jcr Pharmaceuticals Co Ltd | 成長ホルモン含有安定化粉末製剤 |
EP1572217B1 (en) | 2002-12-12 | 2008-08-20 | Nycomed GmbH | Combination medicament of r,r-formoterol and ciclesonide |
WO2004103379A1 (en) | 2003-05-22 | 2004-12-02 | Altana Pharma Ag | Salmeterol and ciclesonide combination |
GB0312148D0 (en) * | 2003-05-28 | 2003-07-02 | Aventis Pharma Ltd | Stabilized pharmaceutical products |
EP1636364A2 (en) * | 2003-06-06 | 2006-03-22 | Senesco Technologies, Inc. | INHIBITION OF APOPTOSIS-SPECIFIC ELF-5A ( EIF-5A1) WITH ANTISENSE OLIGONUCLEOTIDES AND siRNAs AS ANTI-INFLAMMATORY THERAPEUTICS |
AU2004246819A1 (en) | 2003-06-13 | 2004-12-23 | Nycomed Gmbh | Formoterol and ciclesonide combination |
GB0315889D0 (en) * | 2003-07-08 | 2003-08-13 | Aventis Pharma Ltd | Stable pharmaceutical products |
GB0323684D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
GB0323685D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
-
2003
- 2003-05-28 GB GBGB0312148.0A patent/GB0312148D0/en not_active Ceased
-
2004
- 2004-05-27 PL PL04735045T patent/PL1626913T3/pl unknown
- 2004-05-27 KR KR1020057022586A patent/KR20060023539A/ko not_active Application Discontinuation
- 2004-05-27 RS YUP-2005/0882A patent/RS20050882A/sr unknown
- 2004-05-27 JP JP2006530539A patent/JP5175048B2/ja not_active Expired - Lifetime
- 2004-05-27 WO PCT/GB2004/002249 patent/WO2004105727A2/en active Application Filing
- 2004-05-27 CA CA2527088A patent/CA2527088C/en not_active Expired - Fee Related
- 2004-05-27 MX MXPA05012757A patent/MXPA05012757A/es unknown
- 2004-05-27 CN CNA2004800143546A patent/CN1832890A/zh active Pending
- 2004-05-27 AU AU2004243223A patent/AU2004243223A1/en not_active Abandoned
- 2004-05-27 BR BRPI0410701-2A patent/BRPI0410701A/pt not_active IP Right Cessation
- 2004-05-27 AT AT04735045T patent/ATE457163T1/de not_active IP Right Cessation
- 2004-05-27 EP EP04735045A patent/EP1626913B1/en not_active Expired - Lifetime
- 2004-05-27 TW TW093115016A patent/TW200509989A/zh unknown
- 2004-05-27 RU RU2005136869/13A patent/RU2337667C2/ru not_active IP Right Cessation
- 2004-05-27 ES ES04735045T patent/ES2340681T3/es not_active Expired - Lifetime
- 2004-05-27 DE DE602004025463T patent/DE602004025463D1/de not_active Expired - Lifetime
- 2004-05-28 AR ARP040101868A patent/AR047619A1/es not_active Application Discontinuation
-
2005
- 2005-10-26 US US11/259,495 patent/US7736673B2/en not_active Expired - Lifetime
- 2005-11-10 ZA ZA200509099A patent/ZA200509099B/xx unknown
- 2005-11-11 MA MA28600A patent/MA27804A1/fr unknown
- 2005-11-17 NO NO20055443A patent/NO20055443L/no not_active Application Discontinuation
-
2010
- 2010-04-30 US US12/771,557 patent/US8029811B2/en not_active Expired - Lifetime
-
2011
- 2011-08-26 US US13/219,046 patent/US8163299B2/en not_active Expired - Lifetime
-
2012
- 2012-04-02 US US13/437,569 patent/US8440210B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
GB0312148D0 (en) | 2003-07-02 |
RU2337667C2 (ru) | 2008-11-10 |
DE602004025463D1 (de) | 2010-03-25 |
US8163299B2 (en) | 2012-04-24 |
US8440210B2 (en) | 2013-05-14 |
TW200509989A (en) | 2005-03-16 |
JP5175048B2 (ja) | 2013-04-03 |
CN1832890A (zh) | 2006-09-13 |
US20100247585A1 (en) | 2010-09-30 |
MXPA05012757A (es) | 2006-02-13 |
CA2527088A1 (en) | 2004-12-09 |
ATE457163T1 (de) | 2010-02-15 |
US7736673B2 (en) | 2010-06-15 |
RS20050882A (en) | 2007-12-31 |
CA2527088C (en) | 2011-03-01 |
WO2004105727A2 (en) | 2004-12-09 |
AU2004243223A1 (en) | 2004-12-09 |
KR20060023539A (ko) | 2006-03-14 |
US20120247982A1 (en) | 2012-10-04 |
JP2007504277A (ja) | 2007-03-01 |
PL1626913T3 (pl) | 2010-07-30 |
US20110308975A1 (en) | 2011-12-22 |
AR047619A1 (es) | 2006-02-01 |
ES2340681T3 (es) | 2010-06-08 |
ZA200509099B (en) | 2006-08-30 |
BRPI0410701A (pt) | 2006-06-13 |
WO2004105727A3 (en) | 2005-06-16 |
US8029811B2 (en) | 2011-10-04 |
RU2005136869A (ru) | 2006-06-10 |
US20060147537A1 (en) | 2006-07-06 |
MA27804A1 (fr) | 2006-03-01 |
EP1626913A2 (en) | 2006-02-22 |
EP1626913B1 (en) | 2010-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055443L (no) | Stabilisert farmasoytisk produkt | |
TW200420246A (en) | A piece of jewelry | |
NO20091734L (no) | Glucagonreseptorantagonistforbindelser, preparater inneholdende slike forbindelser, og metoder for anvendelse | |
DK1523242T3 (da) | Tabletteret tyggegummi og fremgangsmåde til fremstilling heraf | |
NO20051645L (no) | Nye aminoindozolderivater som medisin og farmakologiske preparater inneholdende disse | |
AP1787A (en) | Novel perindopril salt and pharmaceutical compositions containing same. | |
UA85715C2 (ru) | упакованная изоляционная продукция и способ упаковки изоляционной продукции | |
AU2003244002A1 (en) | Glass plate packing device and method, and package | |
NO20072661L (no) | Rensing av glykopeptider | |
NO20042149L (no) | Farmasoytisk produkt med en adsorbent og anvendelser derav | |
AU2924699A (en) | Tryptase inhibitors | |
IS8249A (is) | Tafla sem felur í sér flúvastatín og karmellósakalsíum | |
ZA200506992B (en) | Fibrate tablet and method for the production thereof | |
NO20074161L (no) | Boy og skrell tablettpakke | |
AU6435700A (en) | Cyclic peptidomimetic urokinase receptor antagonists | |
PL1689374T3 (pl) | Folie samonośne do zastosowania farmaceutycznego i spożywczego | |
DK1411057T3 (da) | [3,,4.a:3,4-c]carbazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
GB0221169D0 (en) | Crystal | |
DK1245565T3 (da) | Indenoindolon-forbindelse, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
AU2003227051A1 (en) | Pack for medicine in capsule, pill or similar form | |
NZ533738A (en) | Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis | |
WO2001006250A3 (en) | Thermo-chemical sensors and uses thereof | |
ATE401351T1 (de) | Lignankomplexe | |
DK1587810T3 (da) | Nye substituerede [1,4]benzodioxino[2,3-e]isoindolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
GB0306555D0 (en) | Display device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |